Chemotherapy, AdjuvantAntineoplastic Combined Chemotherapy ProtocolsBreast NeoplasmsCombined Modality TherapyNeoplasm StagingCyclophosphamideAdjuvants, ImmunologicDisease-Free SurvivalFluorouracilTreatment OutcomeRadiotherapy, AdjuvantCisplatinDoxorubicinAntineoplastic AgentsPrognosisSurvival AnalysisNeoplasm Recurrence, LocalMethotrexateSurvival RateNeoadjuvant TherapyLymphatic MetastasisTegafurDrug Administration ScheduleEpirubicinAntimetabolites, AntineoplasticAdjuvants, PharmaceuticFreund's AdjuvantLung NeoplasmsLevamisoleFollow-Up StudiesColonic NeoplasmsAnthracyclinesPaclitaxelAdenocarcinomaMastectomyTaxoidsTamoxifenCarboplatinKaplan-Meier EstimateColorectal NeoplasmsVinblastineRandomized Controlled Trials as TopicCarcinoma, Non-Small-Cell LungStomach NeoplasmsRetrospective StudiesTime FactorsClinical Trials as TopicTumor Markers, BiologicalOrganoplatinum CompoundsNeoplasm MetastasisLeucovorinLomustineAntineoplastic Agents, HormonalReceptors, EstrogenEtoposideCystectomyGastrectomySarcomaProspective StudiesProportional Hazards ModelsMultivariate AnalysisUracilDeoxycytidinePneumonectomyAntineoplastic Agents, AlkylatingPremenopauseRectal NeoplasmsReceptor, erbB-2OsteosarcomaOxonic AcidTesticular NeoplasmsLymph Node ExcisionRadiotherapyIfosfamideAntibiotics, AntineoplasticSemustineThiotepaLymph NodesMenopauseMitomycinBleomycinAntineoplastic ProtocolsAmenorrheaOvarian NeoplasmsClinical Trials, Phase III as TopicBone NeoplasmsCarcinomaReceptors, ProgesteroneDrug Resistance, NeoplasmRecurrenceNeutropeniaSoft Tissue NeoplasmsMedical OncologyBridged CompoundsChemoradiotherapyChemoradiotherapy, AdjuvantAntineoplastic Agents, PhytogenicRadiotherapy DosageNeoplasms, Germ Cell and EmbryonalAge Factors